These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 28889388)
21. Urinary mRNA biomarker panel for the detection of urothelial carcinoma. Urquidi V; Netherton M; Gomes-Giacoia E; Serie D; Eckel-Passow J; Rosser CJ; Goodison S Oncotarget; 2016 Jun; 7(25):38731-38740. PubMed ID: 27231851 [TBL] [Abstract][Full Text] [Related]
22. MicroRNA expression profiling in bladder cancer: the challenge of next-generation sequencing in tissues and biofluids. Matullo G; Naccarati A; Pardini B Int J Cancer; 2016 May; 138(10):2334-45. PubMed ID: 26489968 [TBL] [Abstract][Full Text] [Related]
23. A modified precipitation method to isolate urinary exosomes. Kanchi Ravi R; Khosroheidari M; DiStefano JK J Vis Exp; 2015 Jan; (95):51158. PubMed ID: 25651044 [TBL] [Abstract][Full Text] [Related]
24. The role of microRNAs in bladder cancer. Enokida H; Yoshino H; Matsushita R; Nakagawa M Investig Clin Urol; 2016 Jun; 57 Suppl 1(Suppl 1):S60-76. PubMed ID: 27326409 [TBL] [Abstract][Full Text] [Related]
25. Urinary cell-free microRNA-106b as a novel biomarker for detection of bladder cancer. Zhou X; Zhang X; Yang Y; Li Z; Du L; Dong Z; Qu A; Jiang X; Li P; Wang C Med Oncol; 2014 Oct; 31(10):197. PubMed ID: 25168920 [TBL] [Abstract][Full Text] [Related]
26. Quantitative Analysis of Exosomal miRNA via qPCR and Digital PCR. Bellingham SA; Shambrook M; Hill AF Methods Mol Biol; 2017; 1545():55-70. PubMed ID: 27943207 [TBL] [Abstract][Full Text] [Related]
27. Evaluation of Cell-Free Urine microRNAs Expression for the Use in Diagnosis of Ovarian and Endometrial Cancers. A Pilot Study. Záveský L; Jandáková E; Turyna R; Langmeierová L; Weinberger V; Záveská Drábková L; Hůlková M; Hořínek A; Dušková D; Feyereisl J; Minář L; Kohoutová M Pathol Oncol Res; 2015 Sep; 21(4):1027-35. PubMed ID: 25827090 [TBL] [Abstract][Full Text] [Related]
28. MicroRNAs: Key Players in Bladder Cancer. Li Q; Wang H; Peng H; Huang Q; Huyan T; Huang Q; Yang H; Shi J Mol Diagn Ther; 2019 Oct; 23(5):579-601. PubMed ID: 31325035 [TBL] [Abstract][Full Text] [Related]
29. Diagnostic Potential of Circulating Tumor Cells, Urinary MicroRNA, and Urinary Cell-Free DNA for Bladder Cancer: A Review. Koguchi D; Matsumoto K; Shiba I; Harano T; Okuda S; Mori K; Hirano S; Kitajima K; Ikeda M; Iwamura M Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012417 [TBL] [Abstract][Full Text] [Related]
30. Variability in microRNA recovery from plasma: Comparison of five commercial kits. Brunet-Vega A; Pericay C; Quílez ME; Ramírez-Lázaro MJ; Calvet X; Lario S Anal Biochem; 2015 Nov; 488():28-35. PubMed ID: 26271186 [TBL] [Abstract][Full Text] [Related]
31. Diagnostic and prognostic value of bladder cancer-related transcript markers in urine. Schmidt J; Propping C; Siow WY; Lohse-Fischer A; Toma M; Baldauf-Twelker A; Hakenberg OW; Wirth MP; Fuessel S J Cancer Res Clin Oncol; 2016 Feb; 142(2):401-14. PubMed ID: 26328914 [TBL] [Abstract][Full Text] [Related]
32. Comparison of MicroRNA Content in Plasma and Urine Indicates the Existence of a Transrenal Passage of Selected MicroRNAs. Pazourkova E; Pospisilova S; Svobodova I; Horinek A; Brisuda A; Soukup V; Hrbacek J; Capoun O; Mares J; Hanus T; Babjuk M; Korabecna M Adv Exp Med Biol; 2016; 924():97-100. PubMed ID: 27753026 [TBL] [Abstract][Full Text] [Related]
33. Quantitative analysis of survivin mRNA expression in urine and tumor tissue of bladder cancer patients and its potential relevance for disease detection and prognosis. Weikert S; Christoph F; Schrader M; Krause H; Miller K; Müller M Int J Cancer; 2005 Aug; 116(1):100-4. PubMed ID: 15761870 [TBL] [Abstract][Full Text] [Related]
34. Role of Exosomal miRNA in Bladder Cancer: A Promising Liquid Biopsy Biomarker. Piao XM; Cha EJ; Yun SJ; Kim WJ Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33567779 [TBL] [Abstract][Full Text] [Related]
35. Cell-free urinary microRNA-99a and microRNA-125b are diagnostic markers for the non-invasive screening of bladder cancer. Zhang DZ; Lau KM; Chan ES; Wang G; Szeto CC; Wong K; Choy RK; Ng CF PLoS One; 2014; 9(7):e100793. PubMed ID: 25014919 [TBL] [Abstract][Full Text] [Related]
36. A two-gene methylation signature for the diagnosis of bladder cancer in urine. Bosschieter J; Nieuwenhuijzen JA; Hentschel A; van Splunter AP; Segerink LI; Vis AN; Wilting SM; Lissenberg-Witte BI; A van Moorselaar RJ; Steenbergen RD Epigenomics; 2019 Feb; 11(3):337-347. PubMed ID: 30706728 [TBL] [Abstract][Full Text] [Related]
37. Evaluation of optimal extracellular vesicle small RNA isolation and qRT-PCR normalisation for serum and urine. Crossland RE; Norden J; Bibby LA; Davis J; Dickinson AM J Immunol Methods; 2016 Feb; 429():39-49. PubMed ID: 26723490 [TBL] [Abstract][Full Text] [Related]
38. Integrative functional genetic-epigenetic approach for selecting genes as urine biomarkers for bladder cancer diagnosis. Eissa S; Matboli M; Essawy NO; Kotb YM Tumour Biol; 2015 Dec; 36(12):9545-52. PubMed ID: 26138586 [TBL] [Abstract][Full Text] [Related]
39. MicroRNA-218 inhibits bladder cancer cell proliferation, migration, and invasion by targeting BMI-1. Cheng Y; Yang X; Deng X; Zhang X; Li P; Tao J; Lu Q Tumour Biol; 2015 Sep; 36(10):8015-23. PubMed ID: 25967457 [TBL] [Abstract][Full Text] [Related]
40. Evaluation of urinary miRNA-96 as a potential biomarker for bladder cancer diagnosis. Eissa S; Habib H; Ali E; Kotb Y Med Oncol; 2015 Jan; 32(1):413. PubMed ID: 25511320 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]